Skip to main content

🏥 Care providers

In this section, you will find a list of our major customers in this segment.

  1. Hospital Universitario de Torrejón
  2. Hospital Ribera Molina
  3. Hospital de Vinalopó
  4. Clinica Dermatológica IGDerma
  5. IDEI - Instituto Dermatología Integral de Madrid
  6. Visiba Care
  7. Clinica de la Asunción
  8. Hospital Puerta del Hierro
  9. Hospital Universitario Doctor Peset

Summary

Here's a screenshot of our sales pipeline for this segment.

last updated at january 28, 2025

screenshot of our sales pipeline

Ribera Salud

In the following videos (one in English, and one in Spanish), Dr Elena Sanchez-Largo explain how they are using Legit.Health at the Hospital de Torrejón, in Madrid. Hospital de Torrejón is one of the hospitals owned by Ribera Salud.

SpanishEnglish

Healthcare providers pain

For profit (private) care providers

For-profit care providers are diverse across Europe, but share some pains:

  1. Lack of specialists.
  2. Difficulty to provide care remotely with a degree of customer satisfaction equiparable to in-person consultation.
  3. High fragmentation regarding digital solutions.

This causes for-profit care providers to suffer frustrations:

  1. Patients wait up to 12 months to receive medical assistance
  2. Insurance companies are ambivalent about reimbursing remote consultations at the same value than in-person consultations.
  3. For-profit care providers are unable to cover the demand of the dermatology market. Their supply capacity does

Government (public) care providers

Government care providers in Europe are at a difficult position due to 3 factors:

  1. General practitioners and nurses have insufficient knowledge about skin diseases and wounds; and there is a lack of specialists.
  2. The incidence of skin disorders and wounds is high and is increasing.
  3. New treatments for severe conditions are very expensive.

Thus, care providers to suffer frustrations:

  1. Patients have to wait up to 1 year to receive medical assistance
  2. Doctors suffer burnout and dermatologists are increasingly switching to cosmetic medicine.
  3. It's difficult to monitor and supervise efficacy of treatments, which makes it difficult to bargain with pharmaceutical companies.

How Legit.Health is helping

For profit (private) care providers

For-profit care providers benefit from:

  1. The Diagnosis Support and the Automatic Severity Assessment Assessment features empower non-specialists to provide a higher degree of care. This improves the
    supply capacity, and thus reduces the waiting time for patients and increases the quantity of medical
    acts they can invoice.
  2. The Patient and Doctor App feature outputs HL7 FHIR®-compliant Diagnostic
    Reports with all the required clinical information. By doing so, the output of the solution is equivalent to a report generated by a physician, which ensures that it will be reimbursed like a medical act, even when the physician did not intervene at all.
  3. The solution covers 232 conditions (soon to be 323) and it is usable by multiple departments: primary care, dermatology and nursing.

Government (public) care providers

Government care providers benefit from:

  1. The Diagnosis Support and the Automatic Severity Assessment features empower non-specialists. This also reduces the workload of the specialists and automates the follow-up of chronic patients.
  2. The Smart Referral feature increases the adequacy of referrals. It scores pre-malignancy, malignancy, severity and outputs a referral index, not only for skin cancer, but for hundreds of conditions.
  3. The Automatic Severity Assessment feature evaluates the effectiveness of treatments. This empowers care providers to supervise the drugs' performance and trigger compensation clauses when the treatment falls short.
  4. The Therapy Success feature predicts how a patient will respond to treatment in a predictive way. This increases the adequacy of prescriptions and dosage. In turn, saves costs and improves safety.
  5. The Patient and Doctor App feature keeps patients adhered to the treatment, increasing efficacy and reducing prescription costs.